United States - English - NLM (National Library of Medicine)

vista pharmaceuticals, inc. - isoxsuprine hydrochloride (unii: v74teq36co) (isoxsuprine - unii:r15ui3245n) - based on a review of this drug by the national academy of sciences -national research council and / or other information, the fda has classified the medications as follows : possibly effective : 1. for the relief of symptoms associated with cerebral vascular insufficiency 2. in peripheral vascular disease of arteriosclerosis obliterans, thromboangitis obliterans (buerger's disease) and raynaud's disease. final classification of the less-than-effective indications requires further investigation. oral there are no known contraindications to oral use when administered in recommended doses. should not be given immediately postpartum or in the presence of arterial bleeding.

United States - English - NLM (National Library of Medicine)

vista pharmaceuticals, inc. - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - sulfamethoxazole 400 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteriar . when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. urinary tract infections: for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli, klebsiella species, enterobacter species, morganella morganii, proteus mirabilis and proteus vulgaris. it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. acute otitis med

Ireland - English - HPRA (Health Products Regulatory Authority)

allergan pharmaceuticals ireland - botulinum toxin type a - powder for solution for injection - 4 allergan units - other muscle relaxants, peripherally acting agents; botulinum toxin

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - raloxifene hydrochloride (unii: 4f86w47br6) (raloxifene - unii:yx9162eo3i) - raloxifene hydrochloride 60 mg

Canada - English - Health Canada

boiron laboratoires - bovista - tablet - 1dh - bovista 1dh - homeopathic products

Canada - English - Health Canada

dolisos laboratoires s.a. - bovista - tablet - 1dh - bovista 1dh - homeopathic products

Canada - English - Health Canada

dolisos laboratoires s.a. - bovista - drops - 2ch - bovista 2ch - homeopathic products

Canada - English - Health Canada

homeocan inc. - bovista - tablet - 1dh - bovista 1dh - homeopathic products

Canada - English - Health Canada

biologische heilmittel heel gmbh - bovista - liquid - 12d - bovista 12d - homeopathic products

Canada - English - Health Canada

biologische heilmittel heel gmbh - bovista - liquid - 4d - bovista 4d - homeopathic products